Loading clinical trials...
Loading clinical trials...
PRODIGE 33 - BALLAD - Phase III Trial Investigating the Potential Benefit of Adjvant Chemotherapy for Small Bowel Adenocarcinoma
Conditions
Interventions
observation alone
LV5FU2
+1 more
Locations
1
France
CHU du Bocage
Dijon, France
Primary Completion Date
September 1, 2023
Last Updated
July 20, 2015
NCT07347314
NCT02976090
Lead Sponsor
Centre Hospitalier Universitaire Dijon
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions